Yale Cancer Center was well represented Thursday at "Hill Day," hosted by the American Association for Cancer Research (AACR) and the Association of American Cancer Institutes (AACI) in Washington, D.C.
The annual visit to Capitol Hill and congressional representatives includes cancer center leaders, researchers, physician-scientists, and other advocates delivering a common message. This year that message was that stable, predictable funding for the National Institutes of Health (NIH) and National Cancer Institute (NCI) is critical for advancing research and care at cancer centers around the country.
YCC's delegation was led by Roy S. Herbst, MD, PhD, Ensign Professor of Medicine, chief of medical oncology and hematology, and chair of AACR's science policy and government affairs committee; the 2024-25 president of AACR Pat LoRusso, DO, chief and associate cancer center director of experimental therapeutics; Katerina Politi, PhD, scientific director, Center for Thoracic Cancers; Meina Wang, PhD, director for education and translational research, medical oncology and hematology